Effectiveness of inactivated COVID-19 vaccine against the severity of Omicron variant

被引：1
作者：
Wang, Hao
Liu, Li
Wu, Tangchun [1 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Educ, Wuhan 430030, Peoples R China
来源：
FRONTIERS OF MEDICINE | 2023年 / 17卷 / 03期
关键词：
SARS-COV-2; INFECTION; RISK; POPULATION; OUTCOMES; BNT162B2;
D O I：
10.1007/s11684-023-0991-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：576 / 580
页数：5
相关论文
共 50 条
[41]   COVID-19 severity and vaccine effectiveness in Malawi: A test-negative case-control study [J].
Sambani, Clara ;
Chikwapulo, Victor ;
Mankhamba, Regina ;
Muwonge, Tonny ;
Thomas, Mavuto ;
Salatiel, Baxter ;
Mandala, Edna ;
Mbabazi, Leah ;
Nakasendwa, Suzan ;
Ayebare, Rodgers R. ;
Mitambo, Collins ;
Kagoli, Matthew ;
Chiwaula, Mabvuto ;
Kambalame, Dzinkambani ;
Chirwa, Triza ;
Chinyamunyamu, Liness ;
Shaweno, Tamrat ;
Dereje, Nebiyu ;
Raji, Tajudeen ;
Kakooza, Francis ;
Fallah, Mosoka P. ;
Banda, Evelyn C. ;
Kazembe, Abigail ;
Matoga, Mitch .
JOURNAL OF PUBLIC HEALTH IN AFRICA, 2025, 16 (01)
[42]   Impact of the influenza vaccine on COVID-19 infection rates and severity [J].
Conlon, Anna ;
Ashur, Carmel ;
Washer, Laraine ;
Eagle, Kim A. ;
Bowman, Marion A. Hofmann .
AMERICAN JOURNAL OF INFECTION CONTROL, 2021, 49 (06) :694-700
[43]   Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico [J].
Antonio Montes-Gonzalez, Jose ;
Arturo Zaragoza-Jimenez, Christian ;
Eduardo Antonio-Villa, Neftali ;
Fermin-Martinez, Carlos A. ;
Ramirez-Garcia, Daniel ;
Vargas-Vazquez, Arsenio ;
Idania Gutierrez-Vargas, Rosaura ;
Garcia-Rodriguez, Gabriel ;
Lopez-Gatell, Hugo ;
Ivan Valdes-Ferrer, Sergio ;
Yaxmehen Bello-Chavolla, Omar .
FRONTIERS IN PUBLIC HEALTH, 2023, 11
[44]   Engineering a dual vaccine against COVID-19 and tuberculosis [J].
Guthrie, Carlyn Monet ;
Tan, Xuejuan ;
Meeker, Amber Cherry ;
Self, Ashton Elisabeth ;
Liu, Lin ;
Cheng, Yong .
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
[45]   COVID-19 Vaccine Effectiveness of Booster Doses Against Delta and Omicron Variants Over Follow-up Times Using Longitudinal Meta-analysis [J].
Mostafavi, Farideh ;
Bahardoust, Mansour ;
Sera, Francesco ;
Amirabadizadeh, Alireza ;
Allahyari, Sepehr ;
Ssentongod, Paddy ;
Karami, Manochehr ;
Nazari, Seyed Saeed Hashemi .
JOURNAL OF RESEARCH IN HEALTH SCIENCES, 2024, 24 (04)
[46]   Eosinopenia predicts poor outcomes in patients with lung cancer with the omicron variant of COVID-19 [J].
Hu, Xiao ;
Tan, Jie ;
Luan, Rumei ;
Ding, Dongyan ;
Yue, Ming ;
Yang, Junling ;
Xue, Qianfei .
FRONTIERS IN MEDICINE, 2025, 12
[47]   COVID-19 Breakthrough Infection after Inactivated Vaccine Induced Robust Antibody Responses and Cross-Neutralization of SARS-CoV-2 Variants, but Less Immunity against Omicron [J].
Suntronwong, Nungruthai ;
Yorsaeng, Ritthideach ;
Puenpa, Jiratchaya ;
Auphimai, Chompoonut ;
Thongmee, Thanunrat ;
Vichaiwattana, Preeyaporn ;
Kanokudom, Sitthichai ;
Duangchinda, Thaneeya ;
Chantima, Warangkana ;
Pakchotanon, Pattarakul ;
Assawakosri, Suvichada ;
Nilyanimit, Pornjarim ;
Klinfueng, Sirapa ;
Wongsrisang, Lakkhana ;
Srimuan, Donchida ;
Thatsanatorn, Thaksaporn ;
Sudhinaraset, Natthinee ;
Wanlapakorn, Nasamon ;
Poovorawan, Yong .
VACCINES, 2022, 10 (03)
[48]   COVID-19 vaccine effectiveness in people with substance use disorder [J].
Huang, Yueqin .
LANCET PSYCHIATRY, 2023, 10 (06) :372-373
[49]   Effectiveness of the COVID-19 vaccine in the Honam region of the Republic of Korea [J].
Shin, In-Sook ;
Lee, Yong-Pyo ;
Lee, Seung-Hoon ;
Lee, Jae-Young ;
Park, Jong-Ha ;
Chung, Yoon-Seok .
OSONG PUBLIC HEALTH AND RESEARCH PERSPECTIVES, 2023, 14 (03) :197-206
[50]   Clinical characteristics and risk factors of severe COVID-19 in hospitalized neonates with omicron variant infection: a retrospective study [J].
Wei, Huijing ;
Wei, Fu ;
Peng, Xiaokang ;
Liu, Pan ;
Tang, Li ;
Liu, Yishan ;
Liao, Shan ;
Bo, Yajing ;
Zhao, Yuzhen ;
Li, Ruina ;
Liu, Xiaoguai ;
Ji, Fanpu .
ITALIAN JOURNAL OF PEDIATRICS, 2024, 50 (01)
12345